Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-28 10:38 am Purchase | 2025-12-31 | 13G | Imperial Petroleum Inc. IMPP | Empery Asset Management LP | 3,182,951 7.130% | 3,182,951 (New Position) | Filing History |
| 2026-01-28 10:35 am Purchase | 2025-12-31 | 13G | Robin Energy Ltd. RBNE | Empery Asset Management LP | 306,574 9.990% | 306,574 (New Position) | Filing History |
| 2026-01-22 1:01 pm Purchase | 2025-12-31 | 13G | Precision BioSciences, Inc. DTIL | Empery Asset Management LP | 2,297,781 9.990% | 2,297,781 (New Position) | Filing History |
| 2026-01-22 12:56 pm Purchase | 2025-12-31 | 13G | Super League Enterprise, Inc. SLE | Empery Asset Management LP | 106,290 9.990% | 106,290 (New Position) | Filing History |
| 2026-01-15 1:23 pm Sale | 2025-12-31 | 13G | Immuneering Corporation IMRX | Empery Asset Management LP | 3,250,775 4.990% | -1,937,980 (-37.35%) | Filing History |
| 2026-01-15 1:21 pm Purchase | 2025-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management LP | 9,043,894 9.990% | 6,545,732 (+262.02%) | Filing History |
| 2026-01-15 1:20 pm Purchase | 2025-12-31 | 13G | Jiuzi Holdings, Inc. JZXN | Empery Asset Management LP | 73,152 4.990% | 73,152 (New Position) | Filing History |
| 2026-01-05 8:05 pm Purchase | 2026-01-01 | 13D | Empery Digital Inc. EMPD | Empery Asset Management LP | 3,030,345 8.970% | 253,751 (+9.14%) | Filing History |
| 2025-12-08 6:33 pm Purchase | 2025-12-04 | 13D | Empery Digital Inc. EMPD | Empery Asset Management LP | 2,776,594 8.210% | 150,000 (+5.71%) | Filing History |
| 2025-10-21 09:04 am Sale | 2025-09-30 | 13G | Theriva Biologics, Inc. TOVX | Empery Asset Management LP | 504,091 4.990% | -449,094 (-47.12%) | Filing History |
| 2025-10-21 09:03 am Sale | 2025-09-30 | 13G | XTI Aerospace, Inc. XTIA | Empery Asset Management LP | 1,602,751 4.990% | -45,212 (-2.74%) | Filing History |
| 2025-10-21 09:02 am Purchase | 2025-09-30 | 13G | Immuneering Corporation IMRX | Empery Asset Management LP | 5,188,755 8.830% | 5,188,755 (New Position) | Filing History |
| 2025-10-21 09:02 am Sale | 2025-09-30 | 13G | Cyngn Inc. CYN | Empery Asset Management LP | 0 0.000% | -609,342 (Position Closed) | Filing History |
| 2025-10-21 09:01 am Purchase | 2025-10-21 | 13G | Jiuzi Holdings, Inc. JZXN | Empery Asset Management LP | 37,691 7.450% | 37,691 (New Position) | Filing History |
| 2025-10-21 09:00 am Sale | 2025-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Empery Asset Management LP | 2,332,948 4.990% | -862,693 (-27.00%) | Filing History |
| 2025-10-21 09:00 am Purchase | 2025-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management LP | 2,498,162 9.990% | 2,498,162 (New Position) | Filing History |
| 2025-07-31 4:37 pm Purchase | 2025-06-30 | 13G | Theriva Biologics, Inc. TOVX | Empery Asset Management LP | 953,185 9.990% | 953,185 (New Position) | Filing History |
| 2025-07-31 4:36 pm Purchase | 2025-06-30 | 13G | XTI Aerospace, Inc. XTIA | Empery Asset Management LP | 1,647,963 9.990% | 1,647,963 (New Position) | Filing History |
| 2025-07-31 4:36 pm Sale | 2025-06-30 | 13G | Tenaya Therapeutics, Inc. TNYA | Empery Asset Management LP | 8,296,276 4.990% | -431,038 (-4.94%) | Filing History |
| 2025-07-31 4:35 pm Purchase | 2025-06-30 | 13G | Outlook Therapeutics, Inc. OTLK | Empery Asset Management LP | 3,195,641 7.570% | 3,195,641 (New Position) | Filing History |